Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)

Valentina Guarneri; Antonio Frassoldati; Federico Piacentini; Gordana Jovic; Simona Giovannelli; Cristina Oliva; PierFranco Conte

doi:10.3816/CBC.2008.n.022

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)

Valentina Guarneri, Antonio Frassoldati, Federico Piacentini, Gordana Jovic, Simona Giovannelli, Cristina Oliva, PierFranco Conte

Istituto Oncologico Veneto

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	192-194
Number of pages	3
Journal	Clinical Breast Cancer
Volume	8
Issue number	2
DOIs	https://doi.org/10.3816/CBC.2008.n.022
Publication status	Published - 2008

Keywords

Epidermal growth factor receptor
Immunohistochemistry
Pathologic complete response

ASJC Scopus subject areas

Cancer Research

Access to Document

10.3816/CBC.2008.n.022

Cite this

Guarneri, V., Frassoldati, A., Piacentini, F., Jovic, G., Giovannelli, S., Oliva, C., & Conte, P. (2008). Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial). Clinical Breast Cancer, 8(2), 192-194. https://doi.org/10.3816/CBC.2008.n.022

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial). / Guarneri, Valentina; Frassoldati, Antonio; Piacentini, Federico; Jovic, Gordana; Giovannelli, Simona; Oliva, Cristina; Conte, PierFranco.

In: Clinical Breast Cancer, Vol. 8, No. 2, 2008, p. 192-194.

Research output: Contribution to journal › Article

@article{4b497f1f64bf4b0ab58065008774a397,

title = "Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)",

keywords = "Epidermal growth factor receptor, Immunohistochemistry, Pathologic complete response",

author = "Valentina Guarneri and Antonio Frassoldati and Federico Piacentini and Gordana Jovic and Simona Giovannelli and Cristina Oliva and PierFranco Conte",

year = "2008",

doi = "10.3816/CBC.2008.n.022",

language = "English",

volume = "8",

pages = "192--194",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)

AU - Guarneri, Valentina

AU - Frassoldati, Antonio

AU - Piacentini, Federico

AU - Jovic, Gordana

AU - Giovannelli, Simona

AU - Oliva, Cristina

AU - Conte, PierFranco

PY - 2008

Y1 - 2008

KW - Epidermal growth factor receptor

KW - Immunohistochemistry

KW - Pathologic complete response

UR - http://www.scopus.com/inward/record.url?scp=43249090582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249090582&partnerID=8YFLogxK

U2 - 10.3816/CBC.2008.n.022

DO - 10.3816/CBC.2008.n.022

M3 - Article

C2 - 18621618

AN - SCOPUS:43249090582

VL - 8

SP - 192

EP - 194

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

IS - 2

ER -